Exclusive special offer and discount title banner vector image

NORTH AMERICA BIOPSY DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

North America Biopsy Devices Market by Product (Needle-Based Biopsy Guns (Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices), Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, Other Products) Market by Application (Oncology, Gastroenterology, Pulmonology, Dermatology, Other Applications) Market by End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) by Geography


MARKET OVERVIEW

The North America biopsy devices market is expected to grow at a CAGR of 7.59% over the forecast period of 2024-2032 and is set to reach a revenue of $xx million by 2032

The North America biopsy devices market is experiencing significant growth, driven by advancements in healthcare technology and an increasing emphasis on early disease detection. Biopsy devices are integral in obtaining tissue samples for diagnostic purposes, aiding in the identification and characterization of various medical conditions, including cancer. In North America, the rising prevalence of cancer and other chronic diseases, coupled with a growing aging population, has led to an upsurge in the demand for biopsy procedures. Additionally, the region benefits from a well-established healthcare infrastructure and increased awareness among both healthcare professionals and the general population regarding the importance of early and accurate diagnoses.

North America Biopsy Devices Market

To Know More About This Report, Request a Free Sample Copy

The market is characterized by a diverse range of biopsy devices, including needle-based biopsy instruments, core biopsy devices, and vacuum-assisted biopsy systems. Technological innovations, such as the integration of imaging guidance systems and minimally invasive techniques, contribute to the market’s expansion. Moreover, the North America biopsy devices market is witnessing a shift towards the adoption of advanced biopsy techniques that offer enhanced precision and reduced invasiveness. Minimally invasive biopsy procedures, such as liquid biopsy and robotic-assisted biopsies, are gaining attention, providing patients with less discomfort and quicker recovery times. The market is also influenced by the continuous efforts of key industry players such as Argon Medical Devices and Cardinal Health in research and development, focusing on the introduction of innovative biopsy technologies.

Government initiatives supporting cancer screening programs and the integration of artificial intelligence in diagnostic procedures further contribute to the market’s expansion. However, challenges such as the high cost of advanced biopsy devices and the need for skilled professionals may impact market growth. Overall, the North America biopsy devices market is positioned for sustained development as it addresses the evolving needs of the healthcare sector and strives to improve diagnostic accuracy and patient outcomes.

The North America biopsy devices market segmentation includes product, application, and end use. The end use segment includes hospitals, ambulatory surgical centers, and diagnostic centers. Hospitals, being primary healthcare providers, represent a major consumer base for biopsy devices in the region. The increasing incidence of various medical conditions, including cancer, has led to a growing need for diagnostic procedures, increasing the demand for biopsy devices in hospital settings. Moreover, the expanding geriatric population, which is more susceptible to diseases requiring biopsy-based diagnoses, further contributes to the market’s growth.

Diagnostic centers centers specialize in providing a range of diagnostic services, including biopsies, to facilitate early and accurate detection of diseases. The rise in awareness regarding the importance of early diagnosis and advancements in biopsy technologies have powered the adoption of biopsy devices in diagnostic centers. The trend towards outpatient services and a focus on timely and efficient diagnostic solutions contribute significantly to the market’s expansion. 

Some of the leading players in the North America biopsy devices market are Inrad Inc, DTR Medical, Cardinal Health, Boston Scientific, etc. 

Inrad Inc is a company based in North America, with its headquarters situated in Northvale, New Jersey, USA. Specializing in the design, development, and manufacturing of medical imaging accessories and devices, Inrad Inc has established itself as a key player in the healthcare industry. The company is known for providing innovative solutions that contribute to advancements in medical imaging technologies.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product, Application, and End Use
Countries AnalyzedUnited States and Canada
Companies AnalyzedCardinal Health, Hologic Inc, Danaher Corporation, Conmed Corporation, Cook Medical, DTR Medical, Inrad Inc, Boston Scientific, Medtronic PLC, Becton Dickinson and Company, Mammotome, Argon Medical Devices
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON BIOPSY DEVICES MARKET
    5. MAJOR MARKET FINDINGS
      1. GROWING EMPHASIS ON PERSONALIZED MEDICINE
      2. EXPANDING APPLICATIONS ACROSS MEDICAL SPECIALITIES
      3. DEVELOPMENT OF COST-EFFECTIVE BIOPSY SOLUTIONS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. RISING PREVALENCE OF CANCER
      2. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
      3. SURGE IN THE NUMBER OF HOSPITALS AND DIAGNOSTIC CENTERS
    2. KEY RESTRAINTS
      1. HIGH RISK OF INFECTION FOR PATIENTS
      2. HIGH COST OF BIOPSY PROCEDURES
      3. LACK OF SKILLED PROFESSIONALS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. SURGE IN THE HEALTHCARE EXPENDITURE
      2. SHIFT TOWARDS PREVENTIVE HEALTHCARE
      3. ADVANCEMENTS IN BIOPSY TECHNOLOGY
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS’ POWER
      3. SUBSTITUTIONS
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. VALUE CHAIN ANALYSIS
      1. RAW MATERIALS
      2. MANUFACTURERS
      3. DISTRIBUTION
      4. END-USERS
  5. MARKET BY PRODUCT
    1. NEEDLE- BASED BIOPSY GUNS
      1. VACUUM-ASSISTED BIOPSY (VAB) DEVICES
      2. FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES
      3. CORE NEEDLE BIOPSY (CNB) DEVICES
    2. BIOPSY GUIDANCE SYSTEMS
    3. BIOPSY NEEDLES
    4. BIOPSY FORCEPS
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. ONCOLOGY
    2. GASTROENTEROLOGY
    3. PULMONOLOGY
    4. DERMATOLOGY
    5. OTHER APPLICATIONS
  7. MARKET BY END USE
    1. HOSPITALS
    2. AMBULATORY SURGICAL CENTERS
    3. DIAGNOSTIC CENTERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA BIOPSY DEVICES MARKET DRIVERS
      3. NORTH AMERICA BIOPSY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN NORTH AMERICA BIOPSY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. CARDINAL HEALTH
      2. HOLOGIC INC
      3. DANAHER CORPORATION
      4. CONMED CORPORATION
      5. COOK MEDICAL
      6. DTR MEDICAL
      7. INRAD INC
      8. BOSTON SCIENTIFIC
      9. MEDTRONIC PLC
      10. BECTON DICKINSON AND COMPANY
      11. MAMMOTOME
      12. ARGON MEDICAL DEVICES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BIOPSY DEVICES

TABLE 2: NORTH AMERICA BIOPSY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: NORTH AMERICA BIOPSY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: NORTH AMERICA BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: NORTH AMERICA BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: NORTH AMERICA BIOPSY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: NORTH AMERICA BIOPSY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: NORTH AMERICA BIOPSY DEVICES MARKET, BY END USE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: NORTH AMERICA BIOPSY DEVICES MARKET, BY END USE, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: NORTH AMERICA BIOPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: NORTH AMERICA BIOPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: KEY PLAYERS OPERATING IN NORTH AMERICA BIOPSY DEVICES MARKET

TABLE 13: LIST OF MERGERS & ACQUISITIONS

TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING 

FIGURE 4: VALUE CHAIN ANALYSIS

FIGURE 5: NORTH AMERICA BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 6: NORTH AMERICA BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY GUNS, 2024-2032 (IN $ MILLION)

FIGURE 7: NORTH AMERICA BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY NEEDLE-BASED BIOPSY GUNS, IN 2023

FIGURE 8: NORTH AMERICA BIOPSY DEVICES MARKET, BY VACUUM-ASSISTED BIOPSY (VAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 9: NORTH AMERICA BIOPSY DEVICES MARKET, BY FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 10: NORTH AMERICA BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY (CNB) DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 11: NORTH AMERICA BIOPSY DEVICES MARKET, BY BIOPSY GUIDANCE SYSTEMS, 2024-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA BIOPSY DEVICES MARKET, BY BIOPSY NEEDLES, 2024-2032 (IN $ MILLION)

FIGURE 13: NORTH AMERICA BIOPSY DEVICES MARKET, BY BIOPSY FORCEPS, 2024-2032 (IN $ MILLION)

FIGURE 14: NORTH AMERICA BIOPSY DEVICES MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)

FIGURE 15: NORTH AMERICA BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 16: NORTH AMERICA BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 17: NORTH AMERICA BIOPSY DEVICES MARKET, BY GASTROENTEROLOGY, 2024-2032 (IN $ MILLION)

FIGURE 18: NORTH AMERICA BIOPSY DEVICES MARKET, BY PULMONOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 19: NORTH AMERICA BIOPSY DEVICES MARKET, BY DERMATOLOGY, 2024-2032 (IN $ MILLION)

FIGURE 20: NORTH AMERICA BIOPSY DEVICES MARKET, BY OTHER APPLICATIONS, 2024-2032 (IN $ MILLION)

FIGURE 21: NORTH AMERICA BIOPSY DEVICES MARKET, GROWTH POTENTIAL, BY END USE, IN 2023

FIGURE 22: NORTH AMERICA BIOPSY DEVICES MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 23: NORTH AMERICA BIOPSY DEVICES MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 24: NORTH AMERICA BIOPSY DEVICES MARKET, BY DIAGNOSTIC CENTERS, 2024-2032 (IN $ MILLION)

FIGURE 25: NORTH AMERICA BIOPSY DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 26: UNITED STATES BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 27: CANADA BIOPSY DEVICES MARKET, 2024-2032 (IN $ MILLION

FAQ’s